Articles
- T Cell CD Markers: Activation, Differentiation and Immune Profiling
- Myeloid and Dendritic Cell CD Markers for Immune Profiling
- How to Select Recombinant CD Antigens for Your Assay
- CD96-CD155/PVR Axis and the TIGIT Checkpoint Network
- CD93 in Tumor Vasculature: An Emerging Target for Cancer Immunotherapy Research
- CD80 and CD86: CD28/CTLA-4 Costimulatory Signaling in Immune Research
- CD70-CD27 Axis in Cancer: CAR-T, ADC and Antibody Research
- CD55 and CD59: Complement Regulation in Cancer and Antibody Research
- CD47-SIRPα Axis: A Macrophage Immune Checkpoint in Cancer Research
- CD39-CD73 Adenosine Pathway in the Tumor Microenvironment
- CD9, CD63 and CD81: Extracellular Vesicle and Exosome Markers
- CD Molecule Nomenclature: New CD Markers and HLDA Updates
- CD Markers for Immune Cell Immunophenotyping: A Practical Guide
- CD Antigens in Antibody, CAR-T, Bispecific and ADC Development
- B Cell CD Markers: From Immunophenotyping to Therapeutic Targets
- Species-Specific Fc Receptor Proteins for Translational Research
- Fcε Receptor Proteins for Allergy and IgE Research
- Fcγ Receptor Proteins for Antibody Effector Function Research
- FcγRIIb (CD32B) Proteins for Inhibitory Immune Signaling Research
- Fcα Receptor and CD89 Proteins for IgA-Mediated Immunity
- FcRn Proteins for Antibody Half-Life and IgG Recycling Studies
- Fc Receptor-Like Proteins in B Cell Biology and Immune Regulation
- Fc Receptors in Monoclonal Antibody and Biosimilar Development
- Fc Receptors in ADCC, ADCP, and CDC-Related Antibody Function